Showing results (521-530 of 2,310) with videos related to
Sort By:
Pageof 231
The Lancet. Neurology|February 26, 2011
Apolipoprotein E in Alzheimer's disease and other neurological disordersPhilip B Verghese, Joseph M Castellano, David M HoltzmanScience Translational Medicine|April 8, 2011
Alzheimer's disease: the challenge of the second centuryDavid M Holtzman, John C Morris, Alison M GoateThe Journal of Pharmacology and Experimental Therapeutics|December 1, 1990
Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamineJ U Adams, C A Paronis, S G HoltzmanPharmacology, Biochemistry, and Behavior|December 1, 1993
Naltrexone in vivo protects mu receptors from inactivation by beta-funaltrexamine, but not kappa receptors from inactivation by nor-binaltorphimineC A Paronis, A B Waddell, S G HoltzmanMolecular Pharmacology|February 24, 2004
Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1Ya-Jen Chang, Michael J Holtzman, Ching-Chow ChenIsrael Journal of Medical Sciences|November 1, 1979
Adenosine deaminase activity of normal lymphocytes and leukemic cellsI Ben-Bassat, F Simoni, F Holtzman, et al.Pharmacology, Biochemistry, and Behavior|December 1, 1982
Enhanced analgesic response to morphine in adult rats exposed to morphine prenatallyM L Kirby, S E DeRossett, S G HoltzmanPharmacology, Biochemistry, and Behavior|March 1, 1994
Assessing spiradoline-like discriminative effects of DuP 747: influence of route of administrationS G Holtzman, G F Steinfels, W K SchmidtMetabolic Brain Disease|September 1, 1986
Late-onset Krabbe disease initially diagnosed as cerebroside sulfatase activator deficiencyA L Fluharty, L Neidengard, D Holtzman, et al.The European Journal of Neuroscience|August 19, 2009
Increased Fos expression among midbrain dopaminergic cell groups during birdsong tutoringE J Nordeen, D A Holtzman, K W NordeenPageof 231